Recall on Lot of Montelukast Sodium Tablets

Updated on Tuesday, September 4, 2018

Camber Pharmaceuticals is recalling one lot of Montelukast sodium tablets because the bottles are labeled "montelukast sodium tablets, 10mg, 30-count" but actually contain 90 tablets of losartan potassium, 50mg.

This mislabeling is concerning since losartan potassium is a anti-hypertensive which can drop blood pressure if this drug is not indicated or prescribed for them. Montelukast tablets are prescribed for allergic rhinitis and symptoms caused by asthma.

Patients concerned that they may have the mislabeled drug should contact their pharmacy to confirm their lot number of their montelukast if they are unable to locate it on the bottle.

The lot number for the recalled product is MON17384, the expiration date is 12/31/2019, and the national drug code is 31722-726-30.